Racial and Ethnic Disparities in Cancer Survival: The Contribution of Tumor, Sociodemographic, Institutional, and Neighborhood Characteristics
- PMID: 29035642
- PMCID: PMC5756323
- DOI: 10.1200/JCO.2017.74.2049
Racial and Ethnic Disparities in Cancer Survival: The Contribution of Tumor, Sociodemographic, Institutional, and Neighborhood Characteristics
Abstract
Purpose Racial/ethnic disparities in cancer survival in the United States are well documented, but the underlying causes are not well understood. We quantified the contribution of tumor, treatment, hospital, sociodemographic, and neighborhood factors to racial/ethnic survival disparities in California. Materials and Methods California Cancer Registry data were used to estimate population-based cancer-specific survival for patients diagnosed with breast, prostate, colorectal, or lung cancer between 2000 and 2013 for each racial/ethnic group (non-Hispanic black, Hispanic, Asian American and Pacific Islander, and separately each for Chinese, Japanese, and Filipino) compared with non-Hispanic whites. The percentage contribution of factors to overall racial/ethnic survival disparities was estimated from a sequence of multivariable Cox proportional hazards models. Results In baseline models, black patients had the lowest survival for all cancer sites, and Asian American and Pacific Islander patients had the highest, compared with whites. Mediation analyses suggested that stage at diagnosis had the greatest influence on overall racial/ethnic survival disparities accounting for 24% of disparities in breast cancer, 24% in prostate cancer, and 16% to 30% in colorectal cancer. Neighborhood socioeconomic status was an important factor in all cancers, but only for black and Hispanic patients. The influence of marital status on racial/ethnic disparities was stronger in men than in women. Adjustment for all covariables explained approximately half of the overall survival disparities in breast, prostate, and colorectal cancer, but it explained only 15% to 40% of disparities in lung cancer. Conclusion Overall reductions in racial/ethnic survival disparities were driven largely by reductions for black compared with white patients. Stage at diagnosis had the largest effect on racial/ethnic survival disparities, but earlier detection would not entirely eliminate them. The influences of neighborhood socioeconomic status and marital status suggest that social determinants, support mechanisms, and access to health care are important contributing factors.
Figures

Comment in
-
Advancing the Science of Cancer Health Disparities Research.J Clin Oncol. 2018 Jan 1;36(1):1-3. doi: 10.1200/JCO.2017.76.0496. Epub 2017 Oct 31. J Clin Oncol. 2018. PMID: 29087770 No abstract available.
Similar articles
-
Who, where, when: Colorectal cancer disparities by race and ethnicity, subsite, and stage.Cancer Med. 2023 Jul;12(13):14767-14780. doi: 10.1002/cam4.6105. Epub 2023 May 22. Cancer Med. 2023. PMID: 37212502 Free PMC article.
-
Disentangling Racial, Ethnic, and Socioeconomic Disparities in Treatment for Colorectal Cancer.Cancer Epidemiol Biomarkers Prev. 2021 Aug;30(8):1546-1553. doi: 10.1158/1055-9965.EPI-20-1728. Epub 2021 Jun 9. Cancer Epidemiol Biomarkers Prev. 2021. PMID: 34108139 Free PMC article.
-
Cancer survival among US whites and minorities: a SEER (Surveillance, Epidemiology, and End Results) Program population-based study.Arch Intern Med. 2002 Sep 23;162(17):1985-93. doi: 10.1001/archinte.162.17.1985. Arch Intern Med. 2002. PMID: 12230422
-
Disparities in Lung Cancer: A Targeted Literature Review Examining Lung Cancer Screening, Diagnosis, Treatment, and Survival Outcomes in the United States.J Racial Ethn Health Disparities. 2024 Jun;11(3):1489-1500. doi: 10.1007/s40615-023-01625-2. Epub 2023 May 19. J Racial Ethn Health Disparities. 2024. PMID: 37204663 Free PMC article. Review.
-
Geographic Distribution of Racial Differences in Renal Cell Carcinoma Mortality.Clin Genitourin Cancer. 2025 Jun;23(3):102324. doi: 10.1016/j.clgc.2025.102324. Epub 2025 Mar 6. Clin Genitourin Cancer. 2025. PMID: 40157898 Review.
Cited by
-
Cardio oncology: Digital innovations, precision medicine and health equity.Front Cardiovasc Med. 2022 Nov 3;9:951551. doi: 10.3389/fcvm.2022.951551. eCollection 2022. Front Cardiovasc Med. 2022. PMID: 36407451 Free PMC article. Review.
-
Racial/ethnic disparities in all-cause and cause-specific death among children with malignant central nervous system tumours: a registry-based cohort retrospective analysis.EClinicalMedicine. 2024 Sep 5;76:102816. doi: 10.1016/j.eclinm.2024.102816. eCollection 2024 Oct. EClinicalMedicine. 2024. PMID: 39290638 Free PMC article.
-
Development and validation of a prognostic nomogram for breast cancer patients who underwent chemoradiotherapy and surgery: a retrospective cohort study based on the SEER database and two Chinese cohorts.Am J Cancer Res. 2023 Nov 15;13(11):5065-5081. eCollection 2023. Am J Cancer Res. 2023. PMID: 38058820 Free PMC article.
-
Multilevel analysis in rural cancer control: A conceptual framework and methodological implications.Prev Med. 2019 Dec;129S:105835. doi: 10.1016/j.ypmed.2019.105835. Epub 2019 Sep 11. Prev Med. 2019. PMID: 31520673 Free PMC article.
-
Obesity and survival among a cohort of breast cancer patients is partially mediated by tumor characteristics.NPJ Breast Cancer. 2019 Oct 2;5:33. doi: 10.1038/s41523-019-0128-4. eCollection 2019. NPJ Breast Cancer. 2019. PMID: 31602394 Free PMC article.
References
-
- Howlader N, Noone AM, Krapcho M, et al.: SEER Cancer Statistics Review (CSR) 1975-2013. http://seer.cancer.gov/csr/1975_2013/
-
- Clegg LX, Li FP, Hankey BF, et al. : Cancer survival among US whites and minorities: A SEER Program population-based study. Arch Intern Med 162:1985-1993, 2002 - PubMed
-
- Aizer AA, Wilhite TJ, Chen MH, et al. : Lack of reduction in racial disparities in cancer-specific mortality over a 20-year period. Cancer 120:1532-1539, 2014 - PubMed
Publication types
MeSH terms
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources